April 14, 2009

IN RE: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation

IN RE: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation

You will be tracking all:

News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes

First Filing


View recent docket activity »

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 17, 2012

    Bayer Pays $15M To Soothe Consumers In Aspirin MDL

    Bayer Corp. has agreed to pay $15 million to resolve class action claims that it misled consumers into believing its combination aspirin drugs had received regulatory approval, according to a settlement motion filed in New York federal court Wednesday.


Parties

To view the parties, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required